DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Epizyme (NASDAQ: EPZM)



company name or ticker

Epizyme Up on Milestone Payment from Glaxo - Analyst Blog

Why Epizyme Inc. Shares Rocketed Higher

Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.

Epizyme Wins Patent Covering Diagnosis, Treatment of Cancers with EZH2 Mutation

Epizyme Is Now Oversold (EPZM)

Epizyme (EPZM): Moving Average Crossover Spotted - Tale of the Tape

What You Ought To Know About Celgene's Deal-Making Magic

Celgene's investment team has made a string of savvy investments in early stage biotech companies.

Epizyme's CEO Discusses Q4 2013 Results - Earnings Call Transcript

Stocks: Insiders Buy at Epizyme and Intergrated Device Technology

Plus, purchases at Genocea Biosciences and Gladstone Investment and a sale at Epizyme.

Top Insider Trades: EPZM IDTI GAIN GNCA

3 Biotech Stocks Rising on Big Volume

See More Articles...